GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

An analysis of differential coding patterns between Medicare Advantage (MA) and Traditional Medicare (TM) plans estimated how much coding differs between insurers and how much extra revenue insurers ...

This study was a prespecified secondary analysis of the SELECT trial, which was designed to determine the effect of ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Not only does it combat diabetes and aid in weight loss, but it also safeguards heart health in all patients at high ...

Credit scores are three-digit numbers that summarize your credit history to a prospective lender. Ranging from 300 to 850, these scores determine if you get approved for loans, credit cards and ...

Mortgage lenders weigh your credit score heavily when deciding whether to approve your application and what rate to offer you. Your credit score is a three-digit number that can range from 300 to 850.

risk reduction with use of semaglutide 2.4 mg in a real-world environment 1 SCORE is a retrospective, observational analysis of 27,963 patients with obesity or overweight and established ...